Catalyst Wire Dossier Catalyst Wire Dossier

TXA Oral Sol 5%

tranexamic acid oral solution 5% · Hyloris Developments
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TXA Oral Sol 5%, covering 2024-08-01 to 2024-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction [Phase 3]

See pricing